Northwest Bioth Cmn (NWBO)

$0.24 +0.04 (21.73%)
Market Cap 372.60M
Revenue (ttm) 1.38M
Net Income (ttm) -83.78M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -6,071.01%
Debt to Equity Ratio 0.00
Volume 10,971,300
Avg Vol 3,644,784
Day's Range N/A - N/A
Shares Out 1.53B
Stochastic %K 86%
Beta -0.70
Analysts Strong Buy
Price Target $2.00

Company Profile

Northwest Biotherapeutics, Inc., a biotechnology company, focuses on developing personalized immune therapies for cancer. The company develops DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product candidate is the DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, that has completed Phase I clinical trials to treat inop...

Industry: Biotechnology
Sector: Healthcare
Phone: 240 497 9024
Address:
4800 Montgomery Lane, Suite 800, Bethesda, United States
Lookinglong
Lookinglong Oct. 26 at 12:56 AM
$NWBO https://x.com/andrewcaravello/status/1982153636869190047?t=AkHWIbC3dW8zv7TznpW0cw&s=19
0 · Reply
TulipTree
TulipTree Oct. 25 at 11:55 PM
$NWBO Just noticed # of “Watchers” is over 13,400. I think ‘twas 13,398 yesterday 🧨
1 · Reply
russwestbrook
russwestbrook Oct. 25 at 11:31 PM
$NWBO
1 · Reply
RODDAVIDSON
RODDAVIDSON Oct. 25 at 11:00 PM
$NWBO how desperate is the BASHER team from EX WANNABE working a Saturday afternoon .. awesome college football games but the C team BASHERS are posting links to others BASHERS and pretending it matters
0 · Reply
Cocacola1971
Cocacola1971 Oct. 25 at 10:31 PM
$NWBO I just checked the clock and the calendar and dang it, it’s not monday morning yet!!!!! if you don’t get any sleep Saturday and Sunday night because you’re waiting on monday can I get a whoop whoop!!!! 🤣🤣
3 · Reply
TalkDoc
TalkDoc Oct. 25 at 10:24 PM
$NWBO when the paid bashers are getting overtime for working weekends, you know things are heating up.
3 · Reply
Donegal
Donegal Oct. 25 at 10:00 PM
$NWBO
0 · Reply
LongBullish
LongBullish Oct. 25 at 9:14 PM
$NWBO Despite some promising clinical trial results for its DCVax-L treatment for glioblastoma, NWBO faces substantial hurdles related to its long-term financial health and regulatory pathway. The company has a history of heavily diluting shareholder value to raise funds, often by issuing more shares or using "death spiral convertibles". The R/S will be an attempt to improve market perception of its financial stability.
1 · Reply
wjmax
wjmax Oct. 25 at 8:55 PM
$NWBO There is a symphony. The p3 trial is just one part of it. https://x.com/StevenBremMD/status/1962268043028918637?t=Xpgx4yNGT4WZ3lIPTrwe8A&s=19
0 · Reply
DeepThought
DeepThought Oct. 25 at 7:50 PM
$NWBO @None_ Don't know how a shelf registration statement works? We've known for a long time that you're not the brightest candles on the cake!
0 · Reply
Latest News on NWBO
No data available.
Lookinglong
Lookinglong Oct. 26 at 12:56 AM
$NWBO https://x.com/andrewcaravello/status/1982153636869190047?t=AkHWIbC3dW8zv7TznpW0cw&s=19
0 · Reply
TulipTree
TulipTree Oct. 25 at 11:55 PM
$NWBO Just noticed # of “Watchers” is over 13,400. I think ‘twas 13,398 yesterday 🧨
1 · Reply
russwestbrook
russwestbrook Oct. 25 at 11:31 PM
$NWBO
1 · Reply
RODDAVIDSON
RODDAVIDSON Oct. 25 at 11:00 PM
$NWBO how desperate is the BASHER team from EX WANNABE working a Saturday afternoon .. awesome college football games but the C team BASHERS are posting links to others BASHERS and pretending it matters
0 · Reply
Cocacola1971
Cocacola1971 Oct. 25 at 10:31 PM
$NWBO I just checked the clock and the calendar and dang it, it’s not monday morning yet!!!!! if you don’t get any sleep Saturday and Sunday night because you’re waiting on monday can I get a whoop whoop!!!! 🤣🤣
3 · Reply
TalkDoc
TalkDoc Oct. 25 at 10:24 PM
$NWBO when the paid bashers are getting overtime for working weekends, you know things are heating up.
3 · Reply
Donegal
Donegal Oct. 25 at 10:00 PM
$NWBO
0 · Reply
LongBullish
LongBullish Oct. 25 at 9:14 PM
$NWBO Despite some promising clinical trial results for its DCVax-L treatment for glioblastoma, NWBO faces substantial hurdles related to its long-term financial health and regulatory pathway. The company has a history of heavily diluting shareholder value to raise funds, often by issuing more shares or using "death spiral convertibles". The R/S will be an attempt to improve market perception of its financial stability.
1 · Reply
wjmax
wjmax Oct. 25 at 8:55 PM
$NWBO There is a symphony. The p3 trial is just one part of it. https://x.com/StevenBremMD/status/1962268043028918637?t=Xpgx4yNGT4WZ3lIPTrwe8A&s=19
0 · Reply
DeepThought
DeepThought Oct. 25 at 7:50 PM
$NWBO @None_ Don't know how a shelf registration statement works? We've known for a long time that you're not the brightest candles on the cake!
0 · Reply
DeepThought
DeepThought Oct. 25 at 7:42 PM
$NWBO @Makeitcometrue An increase of approximately 18% in overall survival, from 16 to 19 months, is clinically relevant and statistically significant, especially in oncology where even modest gains can reflect meaningful therapeutic progress. And now the mMGMT mOS: We have 30.2 mos from randomization vs 21.3 mos from randomization in controls. A + of 9 month is highly significant and indicates a strong therapeutic effect. We are talking about an increase of 41 %! The rGBM numbers will definitely blow your little brain away! One more thing: In the last 17 and 27 years, respectively, one drug has achieved an increase of +2 months for nGBM, and one drug has achieved an increase of +2 months for rGBM! Welcome to the revolution!!
2 · Reply
nokloo_butbigballs
nokloo_butbigballs Oct. 25 at 7:27 PM
$NWBO - funny to see "bears" working weekends ... 😆 🤣 😂 😹 😆 🤣 They are so f'ing #desparate 💥 😆 🤣
1 · Reply
None_
None_ Oct. 25 at 7:23 PM
$NWBO https://x.com/SnackBioTech/status/1981918760199246110
0 · Reply
None_
None_ Oct. 25 at 7:22 PM
$NWBO https://x.com/SnackBioTech/status/1981712694144332272
0 · Reply
Twister8
Twister8 Oct. 25 at 7:19 PM
$NWBO What is and what will be Advent’s biz model? What is their standalone value as a CDMO? Shouldn’t NWBO mgmt inform investors?
1 · Reply
Surforever
Surforever Oct. 25 at 6:43 PM
$NWBO Little reminder from NWBO's 2024 ASM... things that make you go hmmmm... ;o)
2 · Reply
Makeitcometrue
Makeitcometrue Oct. 25 at 6:09 PM
$NWBO This trash worked little to no better than the placebo! I think it is you that knows nothing.
1 · Reply
RecklessRob1
RecklessRob1 Oct. 25 at 6:07 PM
$NWBO 💯💯💯
0 · Reply
JGHersh
JGHersh Oct. 25 at 5:46 PM
$NWBO these negative comments make me lmao. I mean it’s hilarious. They know nothing, they hold five shares, and they don’t care if the science helps the dying. I mean my message to them is kiss my ass and take your five shares to McDonald’s for a nothing burger.
1 · Reply
nokloo_butbigballs
nokloo_butbigballs Oct. 25 at 5:33 PM
$NWBO - The Changing Narratives of the Shorts — and How Reality Crushed Them “DCVax will never work.” → Phase 3 trial proved it dramatically extends survival. “They’ll never publish results in a real journal.” → Results published in JAMA Oncology, one of the most respected medical journals. “They’ll never submit for regulatory approval.” → MHRA submission confirmed and validated. “They’ll never get approved.” → (Next up...) Approval incoming — and the silence will be deafening. 💥 “They’ll never partner with big pharma.” → Ongoing collaborations and manufacturing readiness prove otherwise. “They’ll never scale production.” → Advent and Flaskworks manufacturing expansion says otherwise. “They’ll run out of money.” → They kept funding operations and advancing milestones. “They’ll never survive the lawsuits.” → They turned defense into offense with their market manipulation case. “They’ll never reach commercialization.” → All signs point to global rollout plans already in motion
1 · Reply
Schlood
Schlood Oct. 25 at 5:24 PM
$NWBO 🤷‍♂️🤔
0 · Reply
russwestbrook
russwestbrook Oct. 25 at 5:06 PM
$NWBO
1 · Reply